scholarly journals IMPACTO DA ALTERAÇÃO DE DIMENSÃO VERTICAL NA DISFUNÇÃO TEMPOROMANDIBULAR: REVISÃO INTEGRATIVA

2019 ◽  
Vol 5 (2) ◽  
pp. 143-160
Author(s):  
Laércio Almeida de Melo ◽  
Luciana Braga ◽  
Júlio Faria ◽  
Fabíola Leite ◽  
Jéssica Mayara De Figueirêdo Oséas ◽  
...  

Introdução:A Disfunção Temporomandibular (DTM) é uma condição bastante frequente na população mundial e a identificação de fatores causais, junto ao seu tratamento é de suma relevância para a qualidade de vida dos indivíduos. Objetivo:Objetivou-se por meio de uma revisão sistemática da literatura de todos os tipos de estudos, avaliar se a perda de dimensão vertical impacta no aparecimento das disfunções temporomandibulares. Método:As estratégias de busca foram realizadas nas bases de dados “Cochrane Library”, “MEDLINE”, “Web of Science”, “Scopus”, “LILACS”, “Scielo” e “Google Acadêmico”, utilizando os seguintes descritores e/ou palavras: “Temporomandibular Joint Disorders"; "Craniomandibular Disorders”; “Occlusion Vertical Dimension”; “Occlusion Vertical Dimensions”; “Vertical Dimension of Occlusion”; “Vertical Dimension”. Resultados:Um total de 4 artigos foram incluídos nesta revisão.A maioria dos estudos demostram que na presença de uma DVO diminuída, o sistema estomatognático é capaz de adaptar-se, não provocando o aparecimento de DTM. Conclusões:Como conclusão, os resultados indicam que não há evidência científica suficiente que permita afirmar que a perda de dimensão vertical predispõe ao aparecimento de sinais e sintomas relacionados à disfunção temporomandibular.

2021 ◽  
pp. 19-22
Author(s):  
Chirag Bhatia ◽  
Hirkani Attarde

Objective: This systematic review aimed to compare outcomes between ultrasound (US)-guided arthrocentesis and conventional arthrocentesis for the management of temporomandibular joint disorders (TMDs). Methods: PubMed, MEDLINE, Cochrane Library, Google Scholar and th EBSCOhost databases were searched up to 30 September 2020 for randomized control trials (RCTs) comparing US-guided and conventional arthrocentesis. The review protocol followed the PRISMA guidelines and was registered in PROSPERO (CRD42020211942). The risk of bias of the studies was independently evaluated using Cochrane Risk of Bias tool. Results: Four RCTs were included. It did not demonstrate any statistically signicant difference in pain or maximal mouth opening (MMO) scores after 1 week and 1 month of follow-up between US-guided and conventional arthrocentesis. Studies also reported data on intra-operative needle relocations and operating time but with conicting results. Conclusion: This study indicates that the use of US during arthrocentesis may not improve postoperative pain and MMO in the short term. Further high-quality adequately powered RCTs are required to strengthen current evidence.


2019 ◽  
Vol 24 (2) ◽  
pp. 316-321
Author(s):  
Leonardo Saraiva ◽  
Siglia Adriana Campos Tortelli ◽  
Matheus Santos Gomes Jorge ◽  
Márcia Oliveira Siqueira ◽  
Lia Mara Wibelinger ◽  
...  

Dentre as dores orofaciais crônicas, as disfunções temporomandibulares são as mais comuns. Essa disfunção causa dor, tendo impacto nas atividades do dia a dia e na qualidade de vida das pessoas. Objetivo: verificar os efeitos da ozonioterapia no tratamento e na diminuição da dor da disfunção temporomandibular. Métodos: foi realizada uma revisão sistemática nas bases de dados SciELO, PubMed, Medline Bireme, Lilacs e Cochrane Library, a partir dos descritores: “Temporomandibular Joint Disorders”, “Ozone” e “Ozone therapy” e do equivalente em português “ozonioterapia”, nos idiomas português, inglês e espanhol, no período de março a junho de 2019. Resultados: foram encontrados 16 artigos, mas, após uma análise minuciosa e a aplicação dos critérios de exclusão, foram selecionados 4 artigos completos que preencheram os critérios de inclusão exigidos. Conclusão: a ozonioterapia é um método eficaz e seguro para o tratamento da dor relacionada à disfunção temporomandibular. As quatro pesquisas incluídas neste estudo mostraram que a articulação temporomandibular se cura muito mais rapidamente com a ozonioterapia do que com as outras terapias tradicionais que foram comparadas. Todavia, é importante que se façam futuros estudos para padronizar a questão das concentrações que devem ser utilizadas, bem como o tempo de tratamento da disfunção temporomandibular.


2018 ◽  
Vol 20 (3) ◽  
pp. 17-23
Author(s):  
Beatriz Elena Artigas Sandoval TD, EPB, MCNM

When oral rehabilitation is performed, an important consideration is to reach an orthopedic stabilization, at the end of the treatment. This condition depends on the Temporomandibular Joint and all neuroclusomuscular components. To achieve this, it is necessary to take into account different parameters such as centric occlusion and vertical dimension. In doing so, we decrease the likelihood of different neuroclusomuscular problems, such as Temporomandibular Joint Disorders, Bruxism, periodontal problems, abfractions, fracture of restorations, among others.


2019 ◽  
Vol 90 (3-4) ◽  
pp. 343-370
Author(s):  
Philippe Amat ◽  
Éric Tran Lu Y

Introduction : Le syndrome d’apnées obstructives du sommeil (SAOS) est une affection très répandue et insuffisamment diagnostiquée, ce qui en fait un problème majeur de santé publique et de sécurité. La rééducation myofonctionnelle orofaciale (RMO) a été montrée efficace dans le traitement multidisciplinaire des SAOS de l’enfant, de l’adolescent et de l’adulte et elle est prescrite à plusieurs étapes de ces prises en charge. Objectifs : L’objectif principal de cette revue systématique de la littérature était d’évaluer l’efficacité de la rééducation myofonctionnelle orofaciale (RMO), active ou passive, dans le traitement du syndrome d’apnées obstructives du sommeil chez les enfants, les adolescents et les adultes. Matériel et méthodes : La revue systématique de la littérature fut entreprise à partir des trois bases de données électroniques : Medline (via PubMed),Cochrane Library, Web of Science Core Collection, et complétée par une recherche limitée de la littérature grise (Google Scholar) afin d’identifier les études évaluant l’efficacité de la RMO sur le SAOS. Le critère de jugement principal était une diminution de l’indice d’apnées/hypopnées (IHA) d’au moins cinq épisodes par heure par rapport à l’état initial. Les critères de jugement secondaires étaient une amélioration de la qualité subjective du sommeil, de la qualité du sommeil mesurée par polysomnographie nocturne et de la qualité de vie mesurée subjectivement. Résultats : Seulement dix études répondaient à tous les critères d’inclusion. Huit étaient des essais cliniques contrôlés randomisés, une était une étude de cohorte prospective et une autre était une étude de cohorte rétrospective. Six études étaient consacrées au SAOS de l’adulte et quatre au SAOS pédiatrique. Toutes les études incluses ont été évaluées à « faible risque de biais » d’après les douze critères de risque de biais du Cochrane Back Review Group. D’après les données probantes disponibles, la RMO permet une réduction significative de l’IAH, jusqu’à 90,6 % chez l’enfant et jusqu’à 92,06 % chez l’adulte. Elle permet une diminution significative de l’intensité et de la fréquence du ronflement, participe à une réduction de la somnolence diurne, limite la réapparition des symptômes d’apnée obstructive du sommeil (AOS) après adénoamygdalectomie chez l’enfant et améliore l’adhésion au traitement par ventilation en pression positive continue (PPC). La RMO passive, avec l’assistance apportée au patient par le port d’une orthèse sur mesure à bille, augmente l’observance à la rééducation, permet une réduction significative de l’intensité du ronflement, de l’IAH et un accroissement significatif des voies aérifères supérieures. Conclusions : Les données publiées montrent que la rééducation myofonctionnelle orofaciale est efficace dans les traitements multidisciplinaires des SAOS de l’enfant, de l’adolescent et de l’adulte et devrait être largement prescrite à plusieurs étapes de ces prises en charge. La RMO passive, avec l’orthèse d’avancée mandibulaire à bille conçue par Michèle Hervy-Auboiron, aide à pallier les fréquents défauts d’observance observés lors des traitements par RMO active.


2020 ◽  
Vol 17 (5) ◽  
pp. 472-486
Author(s):  
Lucy Beishon ◽  
Kannakorn Intharakham ◽  
David Swienton ◽  
Ronney B. Panerai ◽  
Thompson G. Robinson ◽  
...  

Background: Cognitive Training (CT) has demonstrated some benefits to cognitive and psychosocial function in Mild Cognitive Impairment (MCI) and early dementia, but the certainty related to those findings remains unclear. Therefore, understanding the mechanisms by which CT improves cognitive functioning may help to understand the relationships between CT and cognitive function. The purpose of this review was to identify the evidence for neuroimaging outcomes in studies of CT in MCI and early Alzheimer’s Disease (AD). Methods: Medline, Embase, Web of Science, PsycINFO, CINAHL, and The Cochrane Library were searched with a predefined search strategy, which yielded 1778 articles. Studies were suitable for inclusion where a CT program was used in patients with MCI or AD, with a structural or functional Magnetic Resonance Imaging (MRI) outcome. Studies were assessed for quality using the Downs and Black criteria. Results: Medline, Embase, Web of Science, PsycINFO, CINAHL, and The Cochrane Library were searched with a predefined search strategy, which yielded 1778 articles. Studies were suitable for inclusion where a CT program was used in patients with MCI or AD, with a structural or functional Magnetic Resonance Imaging (MRI) outcome. Studies were assessed for quality using the Downs and Black criteria. Conclusions: CT resulted in variable functional and structural changes in dementia, and conclusions are limited by heterogeneity and study quality. Larger, more robust studies are required to correlate these findings with clinical benefits from CT.


Antibodies ◽  
2019 ◽  
Vol 8 (2) ◽  
pp. 34 ◽  
Author(s):  
Ahmad Iftikhar ◽  
Hamza Hassan ◽  
Nimra Iftikhar ◽  
Adeela Mushtaq ◽  
Atif Sohail ◽  
...  

Background: Immunotherapy for multiple myeloma (MM) has been the focus in recent years due to its myeloma-specific immune responses. We reviewed the literature on non-Food and Drug Administration (FDA) approved monoclonal antibodies (mAbs) to highlight future perspectives. We searched PubMed, EMBASE, Web of Science, Cochrane Library and ClinicalTrials.gov to include phase I/II clinical trials. Data from 39 studies (1906 patients) were included. Of all the agents, Isatuximab (Isa, anti-CD38) and F50067 (anti-CXCR4) were the only mAbs to produce encouraging results as monotherapy with overall response rates (ORRs) of 66.7% and 32% respectively. Isa showed activity when used in combination with lenalidomide (Len) and dexamethasone (Dex), producing a clinical benefit rate (CBR) of 83%. Additionally, Isa used in combination with pomalidomide (Pom) and Dex resulted in a CBR of 73%. Indatuximab Ravtansine (anti-CD138 antibody-drug conjugate) produced an ORR of 78% and 79% when used in combination with Len-Dex and Pom-Dex, respectively. Conclusions: Combination therapy using mAbs such as indatuximab, pembrolizumab, lorvotuzumab, siltuximab or dacetuzumab with chemotherapy agents produced better outcomes as compared to monotherapies. Further clinical trials investigating mAbs targeting CD38 used in combination therapy are warranted.


2021 ◽  
pp. 030157422110195
Author(s):  
Ashish Agrawal ◽  
TM Chou

Introduction: The objective of this systematic review is to assess the effect of vibrational force on biomarkers for orthodontic tooth movement. Methods: An electronic search was conducted for relevant studies (up to December 31, 2020) on the following databases: Pubmed, Google scholar, Web of Science, Cochrane Library, Wiley Library, and ProQuest Dissertation Abstracts and Thesis database. Hand searching of selected orthodontic journals was also undertaken. The selected studies were assessed for the risk of bias in Cochrane collaboration risk of bias tool. The “traffic plot” and “weighted plot” risk of bias distribution are designed in the RoB 2 tool. The 2 authors extracted the data and analyzed it. Results: Six studies fulfilled the inclusion criteria. The risks of biases were high for 4, low and some concern for other 2 studies. The biomarkers, medium, device, frequency and duration of device, as well as other data were extracted. The outcomes of the studies were found to be heterogenous. Conclusion: One study showed highly statistically significant levels of IL-1 beta with <.001. Rate of tooth movement was correlated with levels of released biomarkers under the influence of vibrational force in 3 studies, but it was found to be significant only in 1 study. It was further observed that vibration does not have any significant reduction in pain and discomfort.


Author(s):  
Bilal Ege ◽  
Zozan Erdogmus ◽  
Esra Bozgeyik ◽  
Mahmut Koparal ◽  
Muhammed Yusuf Kurt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document